These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31930241)

  • 1. Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction.
    Torrieri G; Fontana F; Figueiredo P; Liu Z; Ferreira MPA; Talman V; Martins JP; Fusciello M; Moslova K; Teesalu T; Cerullo V; Hirvonen J; Ruskoaho H; Balasubramanian V; Santos HA
    Nanoscale; 2020 Jan; 12(4):2350-2358. PubMed ID: 31930241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.
    Yu J; Li W; Yu D
    Drug Des Devel Ther; 2018; 12():1697-1706. PubMed ID: 29928113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeting Theranostic System with Mimicking Apoptosis to Promote Myocardial Infarction Repair
    Chen J; Yang J; Liu R; Qiao C; Lu Z; Shi Y; Fan Z; Zhang Z; Zhang X
    Theranostics; 2017; 7(17):4149-4167. PubMed ID: 29158816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
    Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-Responsive Drug-Conjugated Dextran Nanoparticles Enhance Anti-Inflammatory Drug Efficacy.
    Lee S; Stubelius A; Hamelmann N; Tran V; Almutairi A
    ACS Appl Mater Interfaces; 2018 Nov; 10(47):40378-40387. PubMed ID: 30067018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
    Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
    Braga CB; Perli G; Becher TB; Ornelas C
    Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice.
    Ishikawa S; Noma T; Fu HY; Matsuzaki T; Ishizawa M; Ishikawa K; Murakami K; Nishimoto N; Nishiyama A; Minamino T
    PLoS One; 2017; 12(11):e0187894. PubMed ID: 29121663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The double-edged sword effect of macrophage targeting delivery system in different macrophage subsets related diseases.
    Yuan Y; Long L; Liu J; Lin Y; Peng C; Tang Y; Zhou X; Li S; Zhang C; Li X; Zhou X
    J Nanobiotechnology; 2020 Nov; 18(1):168. PubMed ID: 33198758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiosphere-Derived Cells Facilitate Heart Repair by Modulating M1/M2 Macrophage Polarization and Neutrophil Recruitment.
    Hasan AS; Luo L; Yan C; Zhang TX; Urata Y; Goto S; Mangoura SA; Abdel-Raheem MH; Zhang S; Li TS
    PLoS One; 2016; 11(10):e0165255. PubMed ID: 27764217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle Delivery of miRNA-21 Mimic to Cardiac Macrophages Improves Myocardial Remodeling after Myocardial Infarction.
    Bejerano T; Etzion S; Elyagon S; Etzion Y; Cohen S
    Nano Lett; 2018 Sep; 18(9):5885-5891. PubMed ID: 30141949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.
    Carlson S; Helterline D; Asbe L; Dupras S; Minami E; Farris S; Stempien-Otero A
    J Mol Cell Cardiol; 2017 Jul; 108():42-49. PubMed ID: 27262672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembly of pH-sensitive fluorinated peptide dendron functionalized dextran nanoparticles for on-demand intracellular drug delivery.
    Ma S; Zhou J; Wali AR; He Y; Xu X; Tang JZ; Gu Z
    J Mater Sci Mater Med; 2015 Aug; 26(8):219. PubMed ID: 26238777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping molecular agents distributions in whole mice hearts using born-normalized optical projection tomography.
    Vinegoni C; Fumene Feruglio P; Razansky D; Gorbatov R; Ntziachristos V; Sbarbati A; Nahrendorf M; Weissleder R
    PLoS One; 2012; 7(4):e34427. PubMed ID: 22509302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction.
    Leblond AL; Klinkert K; Martin K; Turner EC; Kumar AH; Browne T; Caplice NM
    PLoS One; 2015; 10(9):e0137515. PubMed ID: 26407006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sema3A promotes the resolution of cardiac inflammation after myocardial infarction.
    Rienks M; Carai P; Bitsch N; Schellings M; Vanhaverbeke M; Verjans J; Cuijpers I; Heymans S; Papageorgiou A
    Basic Res Cardiol; 2017 Jul; 112(4):42. PubMed ID: 28540528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement.
    Li J; Shen D; Tang J; Wang Y; Wang B; Xiao Y; Cao C; Shi X; Liu HM; Zhao W; Zhang J
    Eur J Pharmacol; 2019 Jul; 854():307-319. PubMed ID: 31039343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. StemBell therapy stabilizes atherosclerotic plaques after myocardial infarction.
    Woudstra L; Meinster E; VAN Haren L; Kay AM; Koopman M; Belien JAM; Morrison MC; VAN Rossum AC; Helder MN; Juffermans LJM; Niessen HWM; Krijnen PAJ
    Cytotherapy; 2018 Sep; 20(9):1143-1154. PubMed ID: 30107976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.